Association of Two 3D QSAR Analyses. Application to the Study of Partial Agonist Serotonin-3 Ligands

Journal of Chemical Information and Computer Sciences

Volumn 41, Issue 3, 2001, Pages 815-823

  Bureau, Ronan ^a   Daveu, Cyril ^a   Baglin, Isabelle ^a   Sopkova de Oliveira Santos, Jana ^a   Lancelot, Jean Charles ^a   Rault, Sylvain ^a  

^a CENTRE D ETUDES ET DE RECHERCHE SUR LE MÉDICAMENT DE NORMANDIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIGANDS;

CHEMOTHERAPY; CONFORMATIONS; HAMILTONIANS; MOLECULAR DYNAMICS; X RAY CRYSTALLOGRAPHY;

MOLECULAR STRUCTURE;

SEROTONIN 3 RECEPTOR; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; CONFORMATION; DRUG EFFECT; QUANTITATIVE STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

COMPUTER SIMULATION; CRYSTALLOGRAPHY, X-RAY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN AGONISTS;

EID: 0035324942     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci000058x     Document Type: Article

References (31)

1. Martin, G. R.; Humphrey P. P. A, Classification Review Receptors for 5-hydroxytryptamine: Current Perspectives on Classification and Nomenclature. Neuropharmacol. 1994, 33, 261-273.
2. Hoyer, D.; Clarke, D. E.; Fozard, J. R.; Harting, P. R.; Martin, G. R.; Mylecharane, E. J.; Saxena, P. R.; Humphrey, P. A. VII International Union of Pharmacology Classification of Receptors for 5-Hydroxytryptamine (Serotonin). Pharmacol. Rev. 1994, 46, 157-203.
3. Zifa, E.; Fillion, G. 5-Hydroxytryptamine Receptors. Pharmacol. Rev. 1992, 44, 401-458.
4. Saxena, P. R. Serotonin receptors: Subtypes, functional responses and therapeutic relevance. Pharmac. Ther. 1995, 66, 339-368.
5. Sanger, G. J.; Nelson, G. R. Selective and functional 5-hydroxytryptamine receptor antagonism by BRL 43694 (Granisetron). Eur. J. Pharmacol. 1989, 159, 113-124.
6. Butler, A.; Hill, J. M.; Ireland, S. J.; Jordan, C. C.; Meyers, M. B. Pharmacological Properties of GR 3032F, a novel antagonist at 5-HT3 receptors. Br. J. Pharmacol. 1988 94, 387-412.
7. Richardson, B. P.; Engel, G.; Donatsch, P.; Stadler, P. A. Identification of serotonin m-receptor subtypes and their specific blockade by a new class of drugs. Nature 1985, 316, 126-131.
8. Aapro, M. S. 5-HT3 receptor antagonists. An overview of their present status and future potential in cancer therapy-induced emesis. Drugs 1991, 42, 551-568.
9. Rault, S.; Lancelot, J. C.; Prunier, H.; Robba, M.; Renard, P.; Delagrange, P.; Pfeiffer, B.; Caignard, D. H.; Guardiola-Lemaitre, B.; Hamon, M. Novel selective and Partial Agonists of 5-HT3 Receptors. Part 1. Synthesis and Biological Evaluation of Piperazinopyrrolothienopyrazines. J. Med. Chem. 1996, 39, 2068-2080.
10. Prunier, H.; Rault, S.; Lancelot, J. C.; Robba, M.; Renard, P.; Delagrange, P.; Pfeiffer, B.; Caignard, D. H.; Misslin, R. Guardiola-Lemaitre, B. and Hamon, M. Novel selective and Partial Agonists of 5-HT3 Receptors. Part 2. Synthesis and Biological Evaluation of Piperazinopyridopyrrolopyrazines, Piperazinopyrroloquinoxalines, and piperazinopyridopyrroloquinoxalines. J. Med. chem. 1997, 40,1808-1819.
11. Rault, S.; Robba, M.; Lancelot, J. C.; Prunier, H.; Renard, P.; Pfeiffer, B.; Guardiola, B.; Rettori, M. C. Nouveaux ethers d'oximes tricycliques, leurs procédés de fabrication el les compositions pharmaceutiques qui les contiennent. Eur. Pat. Appl. 1994, no. 9415431.
12. Higgins, G. A.; Joharchi, N.; Sellers, E. M. Behavioural Effects of the 5-Hydroxytryptamine3 Receptor Agonists 1-phenyl biguanide and m-chlorophenylbiguanide in Rats. J. Pharmacol. Exp. Ther. 1993, 264, 1440-1449.
13. 3H] granisetron. Biochem. Pharmacol. 1993, 45, 2155-2158.
14. 3H]-GR 65630 binding. Br. J. Pharmacol. 1991, 102, 919-925.
15. 3 serotonin receptors: results of the structure affinity study. Eur. J. Pharmacol. 1989, 168, 387-392.
16. 3 Receptor Ligands and Substance P. J. Neurochem. 1993, 60, 2059-2061.
17. 3 receptors. Quant. Struct.-Act. Relat. 1996, 15, 373-381.
18. Daveu, C.; Bureau, R.; Baglin, I.; Prunier, H.; Lancelot, J. C.; Rault, S. Definition of a pharmacophore for partial agonists of serotonin 5-HT3 receptors. J. Chem. Inf. Comput. Sci. 1999, 39, 362-369.
19. CATALYST Version 3.0 software; Molecular Simulations Inc.: Burlington, MA, 1993.
20. Morreale, A.; Galvez-Ruano, E.; Iriepa-Canalda, I.; Boyd, B. D. Arylpiperazines with serotonin-3 antagonists activity: a comparative molecular field analysis. J. Med. Chem. 1998, 41, 2029-2039.
21. 3 receptors, J. Med. Chem. 1999, 42, 1556-1575.
22. 3 receptor binding site by arylpiperazine derivatives. J. Med. Chem. 1998. 41, 728-741.
23. Cramer, R. D., III; Patterson, D. E.; Bunce, J. D. Comparative Molecular Field Analysis (CoMFA). 1. Effect of shape on Bindings of Steroids to Carrier Proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
24. Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; Sates, D. J.; Swaninathan, S.; Karplus, M. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 1983, 4, 187-217.
25. DISCOVER 95.0/3.00 software; Molecular Simulations Inc.: Burlington, MA, 1993.
26. 3 receptor antagonists and a definition of a model for this receptor site. J. Med. Chem. 1990, 33, 1594-1600.
27. SYBYL 6.0; Tripos Assocation: St. Louis, MO, 1992.
28. Bush, B. L.; Nachbar, R. B. J. Computer-Aided Mol. Design 1993, 7, 587-619.
29. 2-guided region selection for comparative molecular field analysis: a simple method to achieve consistent result. J. Med. Chem. 1995, 38, 1060-1066.
30. Cramer, R. D., III.; Depriest, S. A.; Patterson, D. E.; Hecht, P. The developing practice of Comparative molecular field analysis. In 3D QSAR in Drug Design: Theory, Methods, and Applications; Kubinyi, H., Ed.; ESCOM: Leiden, 1993; pp 443-485.
31. LUNDON2; Lundon Software, Inc.: http://www.geocities.com.